SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-19-145463
Filing Date
2019-05-13
Accepted
2019-05-13 16:58:56
Documents
5
Period of Report
2019-03-11
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d944716d8ka.htm 8-K/A 20835
2 EX-10.5 d944716dex105.htm EX-10.5 281181
3 EX-10.6 d944716dex106.htm EX-10.6 15507
4 EX-10.7 d944716dex107.htm EX-10.7 147209
5 EX-10.8 d944716dex108.htm EX-10.8 89805
  Complete submission text file 0001193125-19-145463.txt   555731
Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38295 | Film No.: 19819145
SIC: 2836 Biological Products, (No Diagnostic Substances)